openPR Logo
Press release

Bacterial Conjunctivitis Drug Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 – 2025

09-18-2017 09:50 AM CET | Health & Medicine

Press release from: CMI - Market Research

Bacterial Conjunctivitis Drug Market – Global Industry

Bacterial conjunctivitis is inflammation of the outermost layer of the eye and inner area of the eyelid. Bacterial conjunctivitis symptoms include swelling, watery eyes, and redness. Bacteria responsible for conjunctivitis include staphylococci, haemophilus, Chlamydia trachomatis, and streptococci. Children and geriatric population are highly prone to bacterial conjunctivitis, however, it affects people of all age groups. The increasing cases of bacterial conjunctivitis demand efficient medication, which supports the growth of bacterial conjunctivitis drugs market. Bacterial conjunctivitis spreads because of poor hygiene, immune compromise, ocular diseases such as dry eye, blepharitis, and contaminated cosmetics. It can be prevented by maintaining proper hygiene and also hand wash reduces the chances of bacterial conjunctivitis.

Bacterial Conjunctivitis Drug Market Taxonomy

By Disease Type:Acute Bacterial Conjunctivitis,Chronic Bacterial Conjunctivitis,.

By Treatment Type:Fluoroquinolones,Macrolides,Aminoglycosides,.

By Route of Administration:Topical,Oral,Intravitreal,.

By End User:Hospitals,Clinics,.

Request Sample Copy of Research: https://www.coherentmarketinsights.com/insight/request-sample/714

Increasing incidences of bacterial conjunctivitis and availability of generic drugs to fuel the market growth

The spread of ophthalmic bacterial infection increased the demand for antibacterial drugs for its treatment. According to National Center for Biotechnology Information (NCBI) 2013 report, in the U.S., there were around 6 million people affected by conjunctivitis. Bacterial conjunctivitis takes around a week to get completely cured and fluoroquinolones are the most preferred drug for the treatment of bacterial conjunctivitis. There are certain drugs in the market that are patented and their patents about to expire, this, in turn, is expected to increase the market for generic drugs, which are of less price as well. Moxeza, vigamox, besivance, and zymaxid are some of the most successful patented drugs about to expire. After patent expiry, these drugs lose their exclusivity, which leads to increase in use of generic drugs. The development of multi-drug resistant variants is expected to fuel the growth of bacterial conjunctivitis drug market. The unnecessary use of antibiotics causes the disease causing bacteria to chemically evolve themselves and become resistant to drugs. This, in turn, may lead to the prescription of strong medication, which includes corticosteroids and high dose of antibiotics.

Rising occurrence of bacterial conjunctivitis demands safe and efficient drugs, which leads to the development of new drugs, such as vancomycin ophthalmic ointment, that are in the clinical trial pipeline and few are pending for approval. Some of the major challenges faced by bacterial conjunctivitis drug market are patent expiry and awareness about the disease that it cures itself in a week. However, the shift in preference toward herbal treatment from pharmacological treatment is expected to create new opportunities in the bacterial conjunctivitis drug market. Moreover, herbal formulation based drugs are widely accepted, which in turn leads to the development and investment in herbal products for the treatment of bacterial conjunctivitis. The aforementioned scenario is expected to support the growth of bacterial conjunctivitis drugs market over the forecast period.

Get Exclusive Discount on This Report: https://www.coherentmarketinsights.com/insight/request-discount/714

Developed regions support the growth of bacterial conjunctivitis drug market

On the basis of geography, bacterial conjunctivitis drug market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the bacterial conjunctivitis drugs market due to the presence of advanced healthcare facilities and reimbursement policies. Europe is the second largest region followed by Asia Pacific. Asia Pacific is expected to witness moderate growth over the forecast period owing to the high awareness about the disease among public and high per capita income.

Key Players in the Bacterial Conjunctivitis Drug Market

Some of the key players contributing to the bacterial conjunctivitis drug market growth are, Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., and Allergan Plc. For increasing market share, the companies adopt various strategies such as mergers and acquisitions. For instance, in 2015, Shire acquired Foresight Biotherapeutics to increase its ophthalmic product pipeline.

Browse Market Research Report: https://www.coherentmarketinsights.com/ongoing-insight/bacterial-conjunctivitis-drug-market-714

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bacterial Conjunctivitis Drug Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 – 2025 here

News-ID: 722087 • Views: 208

More Releases from CMI - Market Research

Adult Vaccines Market, By Types of Vaccines (Monovalent and Multivalent) - Globa …
Vaccination is one of the most effective and safest therapy that protects from diseases and reduces the prevalence of infectious diseases. There are rare side effects associated with vaccinations. Most of the vaccines are recommended on the basis of person’s age, lifestyle, travel destinations, and health conditions such as diabetes, heart diseases, asthma, and chronic obstructive pulmonary disease (COPD). According to Centers for Disease Control and Prevention (CDC), in 2013,
Optogenetics Market, By Sensors (pH Sensors, Genetically Modified Calcium Indica …
Optogenetics is an emerging medical technique, which involves the use of light to control cells in living tissues, especially neurons to help study the characteristics of normal and abnormal brain function. Optogenetics is an emerging field of biotechnology trending among the fields of neuroscience, cardiology, ophthalmology, behavioral science, and other healthcare domains. The technique is widely used to treat neurological disorders such as depression. Depression is caused by chronic stress
X-ray Equipment Market, By Product Type (Computed Tomography, Mobile X-Ray Devic …
X-ray equipment in healthcare is mainly used for imaging of bone structures, tumors, and breast cancer during surgeries, for detecting fractures in bones and teeth, as well as detecting pneumonia. Increasing prevalence of fractures due to osteoporosis, orthopedic disorders, dental problems, and increasing cases of tumor and cancer are expected to boost demand for x-ray equipment in the near future. Rampant advancements in technology and adaptation of advanced medical systems
Sterilization Equipment and Disinfectants Market – Global Industry Insights, T …
Sterilization is process of killing all micro-organisms and pathogens to avoid contamination by means of using physical or chemical treatment. Conversely disinfection is a process to control the growth of micro-organisms and kill a define class of micro-organisms. Disinfection targets narrow spectrum bacteria leaving bacterial spores intact, while sterilization works on broad spectrum micro-organisms. Autoclave uses high pressure and steam to sterilize solid and glass instruments, and liquid mediums in

All 5 Releases


More Releases for Bacteria

Bacteria Sourced Microbial Lipase Market
https://www.qandqmarketresearch.com/reports/7482906/bacteria-sourced-microbial-lipase-market-55 The global Bacteria Sourced Microbial Lipase market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 20192025. The objectives of this study are to define, segment, and project the size of the Bacteria Sourced Microbial Lipase market based on company, product type, end user and key regions. This report studies the global market size of Bacteria Sourced
Global Beneficial Bacteria Market Application, Industry Analysis & Forecast by 2 …
The market for chemical industry is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Global Beneficial Bacteria Market Size, Trends, Revenue and Future Scenario Forecast Until 2025”which offer details about the current trends and analysis, as well as scope for the near future. This research study also covers information about the production, consumption and market share based on different
Anti-bacteria Coating Market: Global Industry Size, Share, Growth, Forecasts
Latest industry research report on: Global Anti-bacteria Coating Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts. In this report, the global Anti-bacteria Coating market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. In addition, drivers, restraints and opportunities, competitive landscape have also been
Probiotic Market Fueled by the Efficiency of the Probiotics Bacteria
Global Probiotic Market: Overview The global probiotic market is expected to be primarily driven by the rising awareness among consumers regarding gut health enhancement. Growing consumption of functional food products and increasing efficiency of probiotic bacteria is further expected to bode well for the global probiotic market’s growth. The demand for probiotic is expected to intensify over the next couple of years owing to the burgeoning awareness among consumers regarding
03-27-2017 | Energy & Environment
PRD
Bacteria, deadwood and climate changeT
With the support of the Austrian Science Fund FWF, an international group of researchers is investigating to what extent the forest floor serves as a carbon sink and how bacteria and fungi interact in this context. The researchers have found deadwood to be populated by a great diversity of life. "The wealth of microorganisms we found in deadwood was astounding", says the microbiologist Judith Ascher-Jenull. It has long been known
Europe Bacteria Colony Counter Market Report 2017
This report studies sales (consumption) of Bacteria Colony Counter in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering AID Boeckel Interscience Molecular Devices Request Sample Report: http://www.reportbazzar.com/request-sample/?pid=825762&ptitle=Europe+Bacteria+Colony+Counter+Market+Report+2017&req=Sample S.M. Scientific Instruments Stuart Equipment Suntex Instruments Synbiosis UVP WTW Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate